Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Gene | PALB2 |
Variant | K862Rfs*9 |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | PALB2 K862Rfs*9 indicates a shift in the reading frame starting at amino acid 862 and terminating 9 residues downstream causing a premature truncation of the 1186 amino acid Palb2 protein (UniProt.org). K862Rfs*9 has not been characterized however, due to the effects of other truncation mutations downstream of K862 (PMID: 31636395, PMID: 31757951), is predicted to lead to a loss of Palb2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
PALB2 mutant PALB2 inact mut PALB2 K862Rfs*9 |
Transcript | NM_024675.4 |
gDNA | chr16:g.23629207delT |
cDNA | c.2585delA |
Protein | p.K862Rfs*9 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001407302.1 | chr16:g.23629207_23629208insTTCTT | c.2584_2585insGAAAA | p.K862Rfs*9 | RefSeq | GRCh38/hg38 |
NM_001407298.1 | chr16:g.23629207_23629208insTTCTT | c.2584_2585insGAAAA | p.K862Rfs*9 | RefSeq | GRCh38/hg38 |
NM_001407300.1 | chr16:g.23629207delT | c.2585delA | p.K862Rfs*9 | RefSeq | GRCh38/hg38 |
NM_001407301.1 | chr16:g.23629207delT | c.2585delA | p.K862Rfs*9 | RefSeq | GRCh38/hg38 |
NM_001407299.1 | chr16:g.23629207delT | c.2585delA | p.K862Rfs*9 | RefSeq | GRCh38/hg38 |
NM_024675.4 | chr16:g.23629207delT | c.2585delA | p.K862Rfs*9 | RefSeq | GRCh38/hg38 |
XM_017023672.2 | chr16:g.23629207delT | c.2585delA | p.K862Rfs*9 | RefSeq | GRCh38/hg38 |
NM_024675.3 | chr16:g.23629207delT | c.2585delA | p.K862Rfs*9 | RefSeq | GRCh38/hg38 |
XM_017023673.2 | chr16:g.23629207delT | c.2585delA | p.K862Rfs*9 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|